209 related articles for article (PubMed ID: 23648139)
1. Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer.
Li XQ; Yang XL; Zhang G; Wu SP; Deng XB; Xiao SJ; Liu QZ; Yao KT; Xiao GH
J Transl Med; 2013 May; 11():114. PubMed ID: 23648139
[TBL] [Abstract][Full Text] [Related]
2. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
[TBL] [Abstract][Full Text] [Related]
3. Association of differential β-catenin expression with Oct-4 and Nanog in oral squamous cell carcinoma and their correlation with clinicopathological factors and prognosis.
Ravindran G; Sawant SS; Hague A; Kingsley K; Devaraj H
Head Neck; 2015 Jul; 37(7):982-93. PubMed ID: 24700702
[TBL] [Abstract][Full Text] [Related]
4. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
Chen MJ; Wang YC; Wu DW; Chen CY; Lee H
Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis.
Zhang S; Wang Y; Dai SD; Wang EH
BMC Cancer; 2011 May; 11():186. PubMed ID: 21599923
[TBL] [Abstract][Full Text] [Related]
6. EPB41 suppresses the Wnt/β-catenin signaling in non-small cell lung cancer by sponging ALDOC.
Yuan J; Xing H; Li Y; Song Y; Zhang N; Xie M; Liu J; Xu Y; Shen Y; Wang B; Zhang L; Yang M
Cancer Lett; 2021 Feb; 499():255-264. PubMed ID: 33242559
[TBL] [Abstract][Full Text] [Related]
7. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
8. HBP1 promoter methylation augments the oncogenic β-catenin to correlate with prognosis in NSCLC.
Tseng RC; Huang WR; Lin SF; Wu PC; Hsu HS; Wang YC
J Cell Mol Med; 2014 Sep; 18(9):1752-61. PubMed ID: 24895061
[TBL] [Abstract][Full Text] [Related]
9. Expression of Bmi1, FoxF1, Nanog, and γ-catenin in relation to hedgehog signaling pathway in human non-small-cell lung cancer.
Gialmanidis IP; Bravou V; Petrou I; Kourea H; Mathioudakis A; Lilis I; Papadaki H
Lung; 2013 Oct; 191(5):511-21. PubMed ID: 23864317
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery.
Xu X; Sun PL; Li JZ; Jheon S; Lee CT; Chung JH
J Thorac Oncol; 2011 Apr; 6(4):716-24. PubMed ID: 21336184
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective.
Gao X; Cai Y; Wang Z; He W; Cao S; Xu R; Chen H
J Transl Med; 2019 Sep; 17(1):308. PubMed ID: 31511014
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of BarH-like homeobox 2 promotes cell proliferation, migration and aerobic glycolysis through Wnt/β-catenin signaling, and predicts a poor prognosis in non-small cell lung carcinoma.
Chen H; Zhang M; Zhang W; Li Y; Zhu J; Zhang X; Zhao L; Zhu S; Chen B
Thorac Cancer; 2018 Mar; 9(3):390-399. PubMed ID: 29341468
[TBL] [Abstract][Full Text] [Related]
13. EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression.
Liu L; Yang Y; Liu S; Tao T; Cai J; Wu J; Guan H; Zhu X; He Z; Li J; Song E; Zeng M; Li M
Oncogene; 2019 Jan; 38(5):747-764. PubMed ID: 30177836
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer.
Dai SD; Wang Y; Miao Y; Zhao Y; Zhang Y; Jiang GY; Zhang PX; Yang ZQ; Wang EH
BMC Cancer; 2009 Jun; 9():178. PubMed ID: 19508730
[TBL] [Abstract][Full Text] [Related]
15. A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.
Pelosi G; Scarpa A; Veronesi G; Spaggiari L; Del Curto B; Moore PS; Maisonneuve P; Sonzogni A; Masullo M; Viale G
Virchows Arch; 2005 Dec; 447(6):969-77. PubMed ID: 16158183
[TBL] [Abstract][Full Text] [Related]
16. Overexpression and cytoplasmic accumulation of Hepl is associated with clinicopathological parameters and poor prognosis in non-small cell lung cancer.
Miao Y; Wang L; Liu Y; Li AL; Liu SL; Cao HY; Zhang XP; Jiang GY; Liu D; Wang EH
Tumour Biol; 2013 Feb; 34(1):107-14. PubMed ID: 23001926
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.
Yu B; Yang X; Xu Y; Yao G; Shu H; Lin B; Hood L; Wang H; Yang S; Gu J; Fan J; Qin W
J Hepatol; 2009 May; 50(5):948-57. PubMed ID: 19303159
[TBL] [Abstract][Full Text] [Related]
18. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type beta-catenin nuclear accumulation in lung tumorigenesis.
Tseng RC; Lin RK; Wen CK; Tseng C; Hsu HS; Hsu WH; Wang YC
Oncogene; 2008 Jul; 27(32):4488-96. PubMed ID: 18372914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
